Lv5
1400 积分 2025-02-19 加入
Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study
4天前
已完结
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
5天前
已完结
Five Cases of Cytokine Release Syndrome in Patients Receiving Cytotoxic Chemotherapy Together With Nivolumab Plus Ipilimumab: A Case Report
8个月前
已完结
Decoding the key compounds and mechanism of Shashen Maidong decoction in the treatment of lung cancer
8个月前
已完结
MET alterations in NSCLC—Current Perspectives and Future Challenges
8个月前
已完结
Lung squamous carcinoma involving the lip and cheek
8个月前
已完结
Traditional Chinese medicine enhances the effectiveness of immune checkpoint inhibitors in tumor treatment: A mechanism discussion
8个月前
已完结
A comprehensive review of immune checkpoint inhibitors for cancer treatment
9个月前
已完结
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
9个月前
已完结
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
10个月前
已完结
皖公网安备34019202002308
